Sahil Kirpekar's Insider Trades & SAST Disclosures

Sahil Kirpekar's most recent trade in ATAI Life Sciences N.V. was a trade of 48,563 Common Shares done at an average price of $1.3 . Disclosure was reported to the exchange on March 21, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer Sale of securities on an exchange or to another person at price $ 1.35 per share. 21 Mar 2025 48,563 115,636 - 1.3 65,560 Common Shares
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 100,000 0 - - Common Shares
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 100,000 164,199 - - Common Shares
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 02 Apr 2024 35,801 64,199 - 1.9 66,232 Common Shares
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 13 Mar 2024 550,000 550,000 - - Stock Option
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 13 Mar 2024 100,000 100,000 - - Restricted Stock Units
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 13 Mar 2024 100,000 100,000 - - Common Shares
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 14 Mar 2023 275,000 275,000 - - Stock Option
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 14 Mar 2023 200,000 200,000 - - Restricted Stock Unit
ATAI Life Sciences N.V.
Sahil Kirpekar Chief Business Officer 01 Dec 2022 750,000 750,000 - - Stock Option
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades